MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$6,817,279
Unit: Dollar
Positive Cash Flow Breakdown
Stock-based compensation
Prepaid expenses and other curre...
Restricted stock issued for cons...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Payment of offering transactions...
Net effect of foreign currency e...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Loss on fair value of warrants over proceeds
-
-
0
-
Net loss
-7,943,587
-6,369,652
-3,628,762
-8,903,188
Stock-based compensation
723,915
650,024
810,796
646,900
Consulting and research expense for restricted shares issued
-
-
-
187,313
Restricted shares issued for consulting and research expense
-
-
618,813
-
Restricted stock issued for consulting expense
198,936
43,651
-
-
Change in fair value of warrant liability
69,829
-254,955
-253,512
-379,311
Prepaid expenses and other current assets
-264,876
-137,114
238,952
-11,443
Australia research and development incentives receivable
-
-
-80,410
-
Accounts payable
-144,773
940,877
-1,138,512
1,452,201
Accrued expenses
80,749
-458,387
-3,021,118
3,498,126
Net cash used in operating activities
-6,750,055
-5,311,328
-7,020,471
-3,486,516
Proceeds from exercise of warrants
0
-
0
572,654
Proceeds from private placement-Private Placement Offering One Twenty Twenty Five
0
-
0
0
Proceeds from private placement-Private Placement Offering Two Twenty Twenty Five
0
-
0
0
Proceeds from private placement-Private Placement Offering One Twenty Twenty Four
-
-
0
-
Proceeds from private placement-Private Placement Offering Three Twenty Twenty Five
0
-
0
0
Proceeds from private placement-Private Placement Offering Two Twenty Twenty Four
-
-
0
-
Proceeds from private placement-Private Placement Offering Four Twenty Twenty Five
0
-
0
0
Proceeds from private placement-Private Placement Offering Three Twenty Twenty Four
-
-
0
-
Proceeds from private placement-Private Placement Offering Five Twenty Twenty Five
-
-
2,253,900
-
Proceeds from private placement-Private Placement Offering Four Twenty Twenty Four
-
-
0
-
Proceeds from private placement-Private Placement Offering Six Twenty Twenty Five
-
-
736,600
-
Proceeds from private placement-Private Placement Offering Five Twenty Twenty Four
-
-
0
-
Proceeds from at-the-market offering
0
-
-
-
Proceeds from private placement-Private Placement Offering Seven Twenty Twenty Five
-
-
1,509,796
-
Proceeds from exercise of stock options
0
38,549
0
0
Proceeds from confidentially marketed public offering
0
33,008,813
420,780
3,779,251
Payment of offering transactions costs
65,000
1,995,041
118,704
498,429
Net cash provided by financing activities
-65,000
31,052,321
4,802,372
4,234,769
Net effect of foreign currency exchange on cash
-2,224
14,086
-15,606
-1,039
Net increase in cash
-6,817,279
25,755,079
-2,233,705
747,214
Cash at beginning of period
34,413,110
8,658,031
10,891,736
9,601,298
Cash at end of period
27,595,831
34,413,110
8,658,031
10,891,736
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase in cash
-$6,817,279
(-1354.97%↓ Y/Y)
Stock-based compensation
$723,915
(-38.34%↓ Y/Y)
Prepaid expenses and
other current assets
-$264,876
(-175.19%↓ Y/Y)
Restricted stock issued for
consulting expense
$198,936
Accrued expenses
$80,749
(-91.94%↓ Y/Y)
Change in fair value of
warrant liability
$69,829
(112.35%↑ Y/Y)
Net cash used in
operating activities
-$6,750,055
(19.04%↑ Y/Y)
Net cash provided by
financing activities
-$65,000
(-100.73%↓ Y/Y)
Net effect of
foreign currency...
-$2,224
(-119.46%↓ Y/Y)
Canceled cashflow
$1,338,305
Net loss
-$7,943,587
(19.47%↑ Y/Y)
Payment of offering
transactions costs
$65,000
(-82.95%↓ Y/Y)
Accounts payable
-$144,773
(-170.27%↓ Y/Y)
Buy us a coffee
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)